Monthly Prescribing Reference5h
Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With RSV
Significantly greater reduction from baseline seen in Wang bronchiolitis clinical score at day 3 for those aged 1 to 24 months ...
cidrap.umn1h
Only 56% of US infants protected by RSV vaccine, antibody
Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of infants were ...
The American Journal of Managed Care2d
Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV
Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective ...
MedPage Today5d
Novel Antiviral Appears Effective for Severe RSV in Infants, Toddlers
Current strategies to prevent severe RSV disease in infants include maternal vaccination with the RSV prefusion F vaccine ...
ArkBio Announces Publication of Phase 3 Clinical Trial Results of Ziresovir for the Treatment of RSV Infection in The New England Journal of Medicine
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...
Daily3d
Ziresovir Shows Promise in Alleviating Bronchiolitis Symptoms in Hospitalized Infants with RSV: Study
China: In a promising development for pediatric care, a recent study has highlighted the efficacy of Ziresovir in treating ...